RARA CRAFT DATABASE for FDA Medical Devices
510(k)K253429

FDA DEVICE FACTS

Genadyne ASTRA NPWT

Genadyne Biotechnologies, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMarch 12, 2026PRODUCT CODEOMPCLINICAL AREASurgery

Indications for use

Genadyne Astra NPWT System is indicated for use in patients who would benefit from negative pressure wound therapy, particularly as the device can be used for wound management by the removal of excess exudates, infectious material and tissue debris. Appropriate wound type include:

- Chronic

- Acute

- Traumatic

- Subacute and dehisced wounds

- Partial thickness burns

- Ulcers (such as diabetic or pressure)

- Flaps and grafts For use by healthcare professional and home use. This NPWT System can only be used with approved dressing kits under K233614. Prescription Use.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026